(Incorporated in Texas) We are an exploration-stage company involved in the mining of critical minerals – rare earth elements. We have the Alpha and Constellation projects in Brazil and the Shiloh Project in the state of Georgia. Our projects are focused on heavy rare earth elements such as neodymium-praseodymium, dysprosium and terbium, which are used […]

(Incorporated in the Cayman Islands) We provide precision machinery from third-party manufacturers for our industrial clients, especially in the automotive and electronics sectors.   (Note: Pacipic Nexus IntelliTech Group filed its F-1 for its IPO on March 20, 2026, and disclosed the terms: 5.0 million shares at a price range of $4.00 to $5.00 to […]

Note: Nuclea Energy withdrew its plans for an IPO  in a letter to the SEC on July 31, 2026. The IPO had previously been postponed. The Canadian company filed its F-1 and disclosed the terms for its IPO on April 13, 2026.) (Incorporated in British Columbia, Canada) We are developing a nuclear micro-reactor to provide […]

(Incorporated in the Cayman Islands) We are a newly organized blank check company – backed by General Catalyst – to target the aerospace and defense sector. We intend to search for target companies in the aerospace and defense sector, including those involved in national security and other associated industries, the prospectus said. Businesses involved with […]

(Incorporated in Delaware) We are a clinical-stage therapeutics company focused on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. Through our differentiated approach, we identify clinically validated mechanisms with established efficacy and safety profiles which had historically been limited by high first-pass metabolism, low bioavailability, and/or side effects. […]

(Incorporated in Delaware) We are a clinical-stage biotech company focused on developing subcutaneous treatments for rare blood coagulation disorders. Our lead therapeutic candidate, sutacimig – also known as HMB-001, has completed Phase 2 trials and it’s ready for Phase 3 for the treatment of Glanzmann thrombasthenia and Phase 2 for Factor VII deficiency. Our therapeutic […]

Note: C2 Capital Group withdrew its plans for its small IPO in a letter to the SEC on Sept. 17, 2026. In early April 2026, C2 Capital Group filed its S-1 for its IPO and disclosed the terms: 3.75 million shares at a price range of $4.00 to $5.00 to raise $16.88 million, if priced at […]

(Incorporated in Delaware) We sell our brands of cold-pressed juices, sodas and wellness shots through our beverage platform. Our brands are Suja Organic, Vive Organic and Slice. Suja Life is a modern beverage platform at the forefront of one of the most powerful consumer transformations of our time: the shift toward functional, better-for-you beverages. We […]

(Incorporated in Delaware) We are a defense technology company that offers a satellite signal-processing platform. Our customers are U.S. government agencies and our allies, including Japan. With over 30 satellites in orbit and additional clusters in development, we maintain a robust global operational footprint. We are committed to expanding our reach, improving our revisit rate […]

(Incorporated in the Cayman Islands) We are a newly organized blank check company. We intend to focus our search for an acquisition target on companies involved in next-gen technology such as  AI-driven applications and smart hardware – as well as in digital entertainment, interactive media and e-commerce ecosystems. Xiaolin Zheng is our CEO and chairwoman. […]